PGC-1α overexpression exacerbates β-amyloid and tau deposition in a transgenic mouse model of Alzheimer's disease. - Wikidata - thesis-toulmin - TriplyDB

PGC-1α overexpression exacerbates β-amyloid and tau deposition in a transgenic mouse model of Alzheimer's disease.

PGC-1α overexpression exacerbates β-amyloid and tau deposition in a transgenic mouse model of Alzheimer's disease.

http://www.wikidata.org/entity/Q30574513

about

Sirt1 and the Mitochondria New insights into PGC-1 coactivators: redefining their role in the regulation of mitochondrial function and beyond Beneficial effects of a pyrroloquinolinequinone-containing dietary formulation on motor deficiency, cognitive decline and mitochondrial dysfunction in a mouse model of Alzheimer's disease.Generation of mice lacking DUF1220 protein domains: effects on fecundity and hyperactivity.Alzheimer's disease: the amyloid hypothesis and the Inverse Warburg effect.Electroacupuncture Upregulates SIRT1-Dependent PGC-1α Expression in SAMP8 Mice.Activation of sirtuin 1 as therapy for the peroxisomal disease adrenoleukodystrophy.PPARγ-coactivator-1α gene transfer reduces neuronal loss and amyloid-β generation by reducing β-secretase in an Alzheimer's disease model.Role of PPAR γ in the Differentiation and Function of Neurons The role of mitochondrial disturbances in Alzheimer, Parkinson and Huntington diseases.Bioenergetics and metabolism: a bench to bedside perspective.Alzheimer's Disease: From Mitochondrial Perturbations to Mitochondrial Medicine.Mitochondria as a target for neuroprotection: implications for Alzheimer´s disease.Mitochondria, Cybrids, Aging, and Alzheimer's Disease.Amyloid precursor protein processing and bioenergetics.The effects of graded levels of calorie restriction: VII. Topological rearrangement of hypothalamic aging networks MH84 improves mitochondrial dysfunction in a mouse model of early Alzheimer's disease.Cell-specific deletion of PGC-1α from medium spiny neurons causes transcriptional alterations and age-related motor impairment.Skeletal Muscle Modulates Huntington's Disease Pathogenesis in Mice: Role of Physical Exercise

P2860

Q26772894-93D7C4EF-1293-4E49-89F6-A9B86E8623D5 Q26996576-3939AE3D-0615-4ACB-95B6-719E83A99668 Q30358683-9DA9F854-6496-4890-B054-DF477BA68737 Q30392455-AE5245D4-7CCF-4ED0-8E66-12B44C5B5877 Q34954180-914402E1-F37A-42EE-9392-C74654DDA2B0 Q36263721-42F0194F-F6F1-4F54-AF65-8FF9200DCC36 Q36288305-96CF684D-6B3C-4D16-8340-EAB545B4DD85 Q37379771-88501291-5D5D-4B5A-907D-255F2E707040 Q38253356-0A04CFE5-0DDB-48D1-9229-7CB33C1163D1 Q38532744-6240FDAE-AF72-4791-8684-86448D327D98 Q38770543-B5824414-6D0E-4FC7-A472-A4BC06904546 Q38872085-5C7576AA-5919-469A-ACE3-AC0F3F1326B5 Q38883083-F7AABC7B-5328-48BB-8235-6B7CD71D95BD Q38932850-4A6F2DF7-4AD5-48F0-8583-BEC462EA2409 Q38933148-D139BFBA-CED8-4B46-A0BC-B4075F90858A Q41809274-A46CF46D-CF43-403F-A5D5-19BCECD3881C Q49491716-1B28E9A6-5756-4251-B755-8E8AD63E7765 Q50421506-59719CF7-DCA7-402A-A41E-7DC385FCB9C2 Q58593129-60080EE8-CE06-4A49-BD01-A8F1D82B7962

P2860

PGC-1α overexpression exacerbates β-amyloid and tau deposition in a transgenic mouse model of Alzheimer's disease.

http://www.wikidata.org/entity/Q30574513

description

2014 nî lūn-bûn

@nan

2014 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

PGC-1α overexpression exacerba ...... model of Alzheimer's disease.

@ast

PGC-1α overexpression exacerba ...... model of Alzheimer's disease.

@en

type

label

PGC-1α overexpression exacerba ...... model of Alzheimer's disease.

@ast

PGC-1α overexpression exacerba ...... model of Alzheimer's disease.

@en

prefLabel

PGC-1α overexpression exacerba ...... model of Alzheimer's disease.

@ast

PGC-1α overexpression exacerba ...... model of Alzheimer's disease.

@en

P1433

Q30574513-08FAB9F7-D6E8-4FFD-8652-FEA3E01B5D02

P1476

Q30574513-C2F6A6AC-3BFE-4304-AA68-CFD64DC67295

P2093

Q30574513-06930728-659C-4AFB-B549-7D8AD38387D7

Q30574513-0F765986-9758-4E95-9939-16B84A422EBD

Q30574513-2F297843-1549-4650-946C-676831C16DC0

Q30574513-4CCD1F36-8DCC-4933-8680-7A6A1C72F4F8

Q30574513-5563B001-CA72-432F-9D29-3E6233712120

Q30574513-A7E79368-9024-4878-92D1-507A0274F3B3

Q30574513-AB2A4A6F-F79A-4707-92CD-2B45ECECA54C

Q30574513-CD72C6A8-D9B0-4565-80C6-663538B2F1DF

Q30574513-EB493EC6-24BE-4E5E-BB38-8DBCC0A3ECC1

Q30574513-F976FC36-343D-4A53-8EE4-0E63DEF75810

P2860

Q30574513-0653AA53-98E6-41FB-B1E8-6972F80BF791

Q30574513-08A4A331-6B77-440F-BF6E-8A0EC194D735

Q30574513-098D4C57-A688-44FB-9F72-D2EBD5041419

Q30574513-12186794-1398-4816-8C60-D29A3AA04D46

Q30574513-15915D79-EA0D-481C-8253-2BD5C45C5E19

Q30574513-1BC75760-A6ED-4AA7-A4A9-23A9BC6E3314

Q30574513-1E55C4D1-3525-4113-8498-F61EA2C35AB6

Q30574513-20793316-3988-41D3-B56B-782A933B0059

Q30574513-2230B77C-BBBF-48AA-9581-2D79CB4D6E3E

Q30574513-23991DBE-1CC9-4EEB-9D06-FE4FEC5DAB2D

P304

Q30574513-61C8BCB5-60A4-440E-9471-8A3C1C00498F

P31

Q30574513-A8A7AE8C-5968-4888-9A6F-00C36E277E2C

P356

Q30574513-BB148439-57C9-477D-93FF-7245D244CD50

P407

Q30574513-14E64BA6-D43C-4F23-BF8B-907E82C0FC99

P433

Q30574513-A7B8ED2E-A75B-499E-BA96-A2538BE30507

P478

Q30574513-80E7F438-1BD7-450C-AB8D-DF51B29C9B59

P50

Q30574513-83E32A9D-9FE9-4BCE-9242-8093F1DA2AE4

Q30574513-E52745A7-61A1-4CA4-9D2B-4616DFDA2322

P577

Q30574513-EAAE1E95-9D10-415D-A1C4-12F482023560

P5875

Q30574513-54569E14-32C9-4BE3-8C49-76FAB7FDE66D

P698

Q30574513-C3739C2E-EFA2-485C-B5D5-416DABC360D3

P921

Q30574513-0DFE44FD-7718-4E90-A03F-0DEAB15A241A

Q30574513-F9AA5D26-7D0E-4AA2-AD66-A257DD7559B4

P932

Q30574513-510A64C8-CC40-4463-94F8-742E6382C55D

P356

P1433

P1476

PGC-1α overexpression exacerba ...... model of Alzheimer's disease.

@en

P2093

Ceyhan Elipenahli

http://www.w3.org/2001/XMLSchema#string

Cliona Stack

http://www.w3.org/2001/XMLSchema#string

Davide Tampellini

http://www.w3.org/2001/XMLSchema#string

M Flint Beal

http://www.w3.org/2001/XMLSchema#string

Magali Dumont

http://www.w3.org/2001/XMLSchema#string

Meri Gerges

http://www.w3.org/2001/XMLSchema#string

Natalia Starkova

http://www.w3.org/2001/XMLSchema#string

Nathalie Launay

http://www.w3.org/2001/XMLSchema#string

Noel Y Calingasan

http://www.w3.org/2001/XMLSchema#string

Shari Jainuddin

http://www.w3.org/2001/XMLSchema#string

P2860

Transcriptional responses to oxidative stress: pathological and toxicological implications

Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic regulator

PARIS (ZNF746) repression of PGC-1α contributes to neurodegeneration in Parkinson's disease

A novel ubiquitin-binding protein ZNF216 functioning in muscle atrophy

PGC-1α, a potential therapeutic target for early intervention in Parkinson's disease

PGC-1alpha expression decreases in the Alzheimer disease brain as a function of dementia

Peroxisome proliferator-activated receptor gamma coactivator 1alpha or 1beta overexpression inhibits muscle protein degradation, induction of ubiquitin ligases, and disuse atrophy

Mitochondrial gene therapy augments mitochondrial physiology in a Parkinson's disease cell model.

A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis

Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1

P304

1745-1755

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1096/FJ.13-236331

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

28

http://www.w3.org/2001/XMLSchema#string

P50

Anatoly Starkov

P577

2014-01-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259626502

http://www.w3.org/2001/XMLSchema#string

P698

24398293

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

3963016

http://www.w3.org/2001/XMLSchema#string